Verve Therapeutics Inc (VERV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VERV | TBPH | SPRY | ||
| Company | Verve Therapeutics Inc | Theravance Bio Ord | Ars Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 11.14 | 19.42 | 9.36 | ||
| High | 11.25 | 19.94 | 9.42 | ||
| Low | 11.10 | 19.16 | 8.86 | ||
| Latest | 11.13 | 19.66 | 9.00 | ||
| Change | +0.03 | +0.23 | -0.44 | ||
| % Change | +0.27% | +1.18% | -4.66% | ||
| Volume | 10,306,600 | 630,800 | 892,500 | ||
| 20-Day Average Volume | 4,353,540 | 417,370 | 1,221,320 | ||
| Previous Close | 11.10 | 19.43 | 9.44 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 11.11 | 19.57 | 9.80 | ||
| 20-Day Raw Stochastic | 52.27% | 50.95% | 17.18% | ||
| 20-Day Relative Strength | 74.99 | 52.91 | 41.65 | ||
| Weighted Alpha | -17.94 | +110.70 | -33.64 | ||
| Today's Opinion | 100% Buy | 96% Buy | 88% Sell | ||
| Previous Opinion | 88% Buy | 80% Buy | 88% Sell | ||
| Last Month's Opinion | 56% Buy | 100% Buy | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.64% since 07/17/25 | +1.34% since 02/12/26 | +2.16% since 02/12/26 | ||
| Low | 10.90 on 07/18/25 | 18.69 on 02/17/26 | 8.61 on 02/13/26 | ||
| High | 11.25 on 07/24/25 | 20.40 on 02/17/26 | 9.64 on 02/19/26 | ||
| 1-Month | |||||
| %Chg | -0.36% since 06/24/25 | -3.72% since 01/20/26 | -13.88% since 01/20/26 | ||
| Low | 10.90 on 07/18/25 | 18.45 on 02/11/26 | 8.61 on 02/13/26 | ||
| High | 11.34 on 07/02/25 | 21.03 on 01/22/26 | 10.88 on 01/23/26 | ||
| 3-Month | |||||
| %Chg | +92.56% since 04/24/25 | +9.83% since 11/20/25 | +33.73% since 11/20/25 | ||
| Low | 3.89 on 05/29/25 | 17.25 on 12/17/25 | 6.66 on 11/21/25 | ||
| High | 11.40 on 06/17/25 | 21.03 on 01/22/26 | 13.15 on 01/12/26 | ||
| 6-Month | |||||
| %Chg | +40.71% since 01/24/25 | +46.83% since 08/20/25 | -38.36% since 08/20/25 | ||
| Low | 2.86 on 04/09/25 | 13.37 on 08/21/25 | 6.66 on 11/21/25 | ||
| High | 11.40 on 06/17/25 | 21.03 on 01/22/26 | 15.09 on 08/21/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 992,162 | 996,212 | 889,641 | ||
| Shares Outstanding, K | 89,143 | 50,672 | 98,849 | ||
| Annual Sales | 32,330,000 | 64,380,000 | 89,150,000 | ||
| Annual Net Income | -198,710,000 | -56,420,000 | 8,000,000 | ||
| Last Quarter Sales | 32,980,000 | 19,990,000 | 32,500,000 | ||
| Last Quarter Net Income | -31,030,000 | 3,620,000 | -51,150,000 | ||
| 60-Month Beta | 2.23 | 0.15 | 0.79 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.35 on 05/14/25 | 0.04 on 11/10/25 | -0.52 on 11/10/25 | ||
| Latest Earnings Date | 08/14/25 | 02/25/26 | 03/19/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 41.34 | 0.00 | ||